Bradfordhill-Clinical Area ( Site 0202)
Bradfordhill-Clinical Area ( Site 0202)
Santiago, Region M. de Santiago, Chile1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65) | autosomal dominant Parkinson disease 4 | Active, not recruiting | Phase 2 | 2026-02-09 | NCT06504394 |